価格表

在庫・価格 : 2025年08月04日 00時46分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
ErbB2/Fc Chimera, Human, Recombinant, Carrier-free
データシート
1129-ER-050 RSDアールアンドディー システムズ
R&D Systems, Inc.
50 μg ¥71,000 1個 追加

在庫・価格 : 2025年08月04日 00時46分 現在

ErbB2/Fc Chimera, Human, Recombinant, Carrier-free

  • 商品コード:1129-ER-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥71,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Chmielewski M et al. T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity. J. Immun
Chmielewski M et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
2 Menotti L et al. A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors. J. Virol. 2006 Jun;80(11):5531-9
Menotti L et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Ahmed N et al. Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 2007 Jun;67(12):5957-64
Ahmed N et al
2007/01/01
Species: Human, Application: Flow Cytometry, Sample type: Whole Cells PubMed
4 Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
Gonzalez RM et al
2008/01/01
Application: ELISA Standard, Sample Type: N/A PubMed
5 Serpe M et al. The BMP-binding protein Crossveinless 2 is a short-range, concentration-dependent, biphasic modulator of BMP signaling in Drosophila. Dev. Cell 2008 Jun;14(6):940-53
Serpe M et al
2008/01/01
Application: Binding Assay, Sample Type: recombinant CV2 PubMed
6 Afshar S et al. Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer. Mol. Cancer Ther. 2009 Jan;8(1):185-93
Afshar S et al
2009/01/01
Application: Bioassay, Sample Type: N/A PubMed
7 Ahmed N et al. Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol. Ther. 2009 Oct;17(10):1779-87
Ahmed N et al
2009/01/01
Application: Binding Assay, Sample Type: Whole Cells PubMed
8 Feldwisch J et al. Design of an optimized scaffold for affibody molecules. J. Mol. Biol. 2010 Apr;398(2):232-47
Feldwisch J et al
2010/01/01
Application: Binding Assay,Dot blot, Sample Type: affibody molecule,affybody molecule PubMed
9 Conrad AH et al. Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions. Invest. Ophthalmol. Vis. Sci. 2010 Sep;51(9):4500-15
Conrad AH et al
2010/01/01
Application: Other: See notes, Sample Type: Other: Corneal Stromal GAGs PubMed
10 Axup JY et al. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(40):16101-6
Axup JY et al
2012/01/01
Application: Binding Assay PubMed
11 Frese K et al. An automated immunoassay for early specificity profiling of antibodies. MAbs ;5(2):279-87
Frese K et al
Application: Bioassay, Sample Type: antibody PubMed
12 Kang JC et al. Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells. MAbs ;6(2):340-53
Kang JC et al
Application: Surface Plamon Resonance, Sample Type: Whole Cells PubMed
13 Hussain S et al. Quantity and accessibility for specific targeting of receptors in tumours. Sci Rep 2014;4:5232
Hussain S et al
2014/01/01
Application: Bioassay, Sample Type: cell line PubMed
14 Nilvebrant J et al. Engineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albumin. PLoS ONE 2014;9(8):e103094
Nilvebrant J et al
2014/01/01
Application: Bioassay,Surface Plasmon Resonance, Sample Type: phage library,protein PubMed
15 Sch旦nfeld K et al. Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor. Mol. Ther. 2015 Feb;23(2):330-8
Sch旦nfeld K et al
2015/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
16 Liu Z et al. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism. J. Biol. Chem. 2015 Mar;290(12):7535-62
Liu Z et al
2015/01/01
Application: ELISA development, Sample Type: recombinant protein PubMed
17 Lin CC et al. The adjuvant effects of high-molecule-weight polysaccharides purified from Antrodia cinnamomea on dendritic cell function and DNA vaccines. PLoS ONE 2015;10(2):e0116191
Lin CC et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
18 Gu J et al. Identification of anti-ErbB2 dual variable domain immunoglobulin (DVD-Ig™) proteins with unique activities. PLoS ONE 2014;9(5):e97292
Gu J et al
2014/01/01
Application: Binding, Sample Type: Whole Cells PubMed
19 VanSeggelen H et al. T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice. Mol. Ther. 2015 Oct;23(10):1600-10
VanSeggelen H et al
2015/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
20 Zhou Q et al. Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors. J. Immunol. 2015 Sep;195(5):2493-501
Zhou Q et al
2015/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
21 Kanojia D et al. Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases. Stem Cells 2015 Oct;33(10):2985-94
Kanojia D et al
2015/01/01
Application: Bioassay, Sample Type: Cell Culture Supernates PubMed
22 Leung KM et al. A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis. Mol. Ther. 2015 Nov;23(11):1722-33
Leung KM et al
2015/01/01
Application: Bioassay, Sample Type: recombinant protein PubMed
23 Selis F et al. Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen. Int J Mol Sci 2016 Apr;17(4):491
Selis F et al
2016/01/01
Application: ELISA capture, Sample Type: recombinant protein PubMed
24 Leung I et al. A Highly Diverse and Functional Naïve Ubiquitin Variant Library for Generation of Intracellular Affinity Reagents. J. Mol. Biol. 2017 Jan;429(1):115-127
Leung I et al
2017/01/01
Application: Direct ELISA, Sample Type: protein PubMed
25 Tobias J et al. Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide. BMC Cancer 2017 Feb;17(1):118
Tobias J et al
2017/01/01
Application: Bioassay, Sample Type: Serum PubMed
26 Petrovic B et al. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins. PLoS Pathog. 2017 Apr;13(4):e1006352
Petrovic B et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Chmielewski M et al. T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity. J. Immun
    Chmielewski M et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Menotti L et al. A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors. J. Virol. 2006 Jun;80(11):5531-9
    Menotti L et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ahmed N et al. Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 2007 Jun;67(12):5957-64
    Ahmed N et al
    2007/01/01
  • 備考:
    Species: Human, Application: Flow Cytometry, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
    Gonzalez RM et al
    2008/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Serpe M et al. The BMP-binding protein Crossveinless 2 is a short-range, concentration-dependent, biphasic modulator of BMP signaling in Drosophila. Dev. Cell 2008 Jun;14(6):940-53
    Serpe M et al
    2008/01/01
  • 備考:
    Application: Binding Assay, Sample Type: recombinant CV2
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Afshar S et al. Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer. Mol. Cancer Ther. 2009 Jan;8(1):185-93
    Afshar S et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ahmed N et al. Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol. Ther. 2009 Oct;17(10):1779-87
    Ahmed N et al
    2009/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Feldwisch J et al. Design of an optimized scaffold for affibody molecules. J. Mol. Biol. 2010 Apr;398(2):232-47
    Feldwisch J et al
    2010/01/01
  • 備考:
    Application: Binding Assay,Dot blot, Sample Type: affibody molecule,affybody molecule
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Conrad AH et al. Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions. Invest. Ophthalmol. Vis. Sci. 2010 Sep;51(9):4500-15
    Conrad AH et al
    2010/01/01
  • 備考:
    Application: Other: See notes, Sample Type: Other: Corneal Stromal GAGs
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Axup JY et al. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(40):16101-6
    Axup JY et al
    2012/01/01
  • 備考:
    Application: Binding Assay
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Frese K et al. An automated immunoassay for early specificity profiling of antibodies. MAbs ;5(2):279-87
    Frese K et al
  • 備考:
    Application: Bioassay, Sample Type: antibody
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Kang JC et al. Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells. MAbs ;6(2):340-53
    Kang JC et al
  • 備考:
    Application: Surface Plamon Resonance, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Hussain S et al. Quantity and accessibility for specific targeting of receptors in tumours. Sci Rep 2014;4:5232
    Hussain S et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: cell line
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Nilvebrant J et al. Engineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albumin. PLoS ONE 2014;9(8):e103094
    Nilvebrant J et al
    2014/01/01
  • 備考:
    Application: Bioassay,Surface Plasmon Resonance, Sample Type: phage library,protein
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Sch旦nfeld K et al. Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor. Mol. Ther. 2015 Feb;23(2):330-8
    Sch旦nfeld K et al
    2015/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Liu Z et al. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism. J. Biol. Chem. 2015 Mar;290(12):7535-62
    Liu Z et al
    2015/01/01
  • 備考:
    Application: ELISA development, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Lin CC et al. The adjuvant effects of high-molecule-weight polysaccharides purified from Antrodia cinnamomea on dendritic cell function and DNA vaccines. PLoS ONE 2015;10(2):e0116191
    Lin CC et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Gu J et al. Identification of anti-ErbB2 dual variable domain immunoglobulin (DVD-Ig™) proteins with unique activities. PLoS ONE 2014;9(5):e97292
    Gu J et al
    2014/01/01
  • 備考:
    Application: Binding, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    VanSeggelen H et al. T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice. Mol. Ther. 2015 Oct;23(10):1600-10
    VanSeggelen H et al
    2015/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Zhou Q et al. Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors. J. Immunol. 2015 Sep;195(5):2493-501
    Zhou Q et al
    2015/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Kanojia D et al. Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases. Stem Cells 2015 Oct;33(10):2985-94
    Kanojia D et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Leung KM et al. A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis. Mol. Ther. 2015 Nov;23(11):1722-33
    Leung KM et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Selis F et al. Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen. Int J Mol Sci 2016 Apr;17(4):491
    Selis F et al
    2016/01/01
  • 備考:
    Application: ELISA capture, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Leung I et al. A Highly Diverse and Functional Naïve Ubiquitin Variant Library for Generation of Intracellular Affinity Reagents. J. Mol. Biol. 2017 Jan;429(1):115-127
    Leung I et al
    2017/01/01
  • 備考:
    Application: Direct ELISA, Sample Type: protein
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Tobias J et al. Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide. BMC Cancer 2017 Feb;17(1):118
    Tobias J et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Petrovic B et al. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins. PLoS Pathog. 2017 Apr;13(4):e1006352
    Petrovic B et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed